SPP1 and prostate carcinoma: Several studies indicated OPN expression in various human malignancies, acting as a marker of malignancy in prostate cancer, osteosarcoma, glioblastoma, squamos cell carcinoma, breast cancer and melanoma (reviewed in ref. 33).